Infant Bacterial Therapeutics AB (IFTBF)
6.18
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Infant Bacterial Therapeutics Total Liabilities (Quarterly) : 6.354M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 6.354M |
| December 31, 2025 | 6.120M |
| September 30, 2025 | 5.728M |
| June 30, 2025 | 6.178M |
| March 31, 2025 | 5.415M |
| December 31, 2024 | 6.272M |
| September 30, 2024 | 3.480M |
| June 30, 2024 | 5.644M |
| March 31, 2024 | 6.690M |
| December 31, 2023 | 4.582M |
| September 30, 2023 | 3.743M |
| June 30, 2023 | 3.376M |
| March 31, 2023 | 2.358M |
| December 31, 2022 | 1.719M |
| September 30, 2022 | 2.211M |
| June 30, 2022 | 1.991M |
| March 31, 2022 | 3.639M |
| December 31, 2021 | 1.461M |
| September 30, 2021 | 1.141M |
| Date | Value |
|---|---|
| June 30, 2021 | 2.091M |
| March 31, 2021 | 1.198M |
| December 31, 2020 | 1.238M |
| September 30, 2020 | 1.704M |
| June 30, 2020 | 0.9623M |
| March 31, 2020 | 1.170M |
| December 31, 2019 | 0.8414M |
| September 30, 2019 | 0.7544M |
| June 30, 2019 | 0.7013M |
| March 31, 2019 | 0.5396M |
| December 31, 2018 | 0.7505M |
| September 30, 2018 | 1.008M |
| June 30, 2018 | 1.185M |
| March 31, 2018 | 0.9745M |
| December 31, 2017 | 0.8126M |
| September 30, 2017 | 0.4892M |
| June 30, 2017 | 1.023M |
| March 31, 2017 | 0.4774M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Orexo AB | 25.78M |
| Swedencare AB | 295.65M |
| Camurus AB | 56.25M |
| Moberg Pharma AB | 1.926M |
| AstraZeneca PLC | 66.63B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.02M |
| Shareholders Equity (Quarterly) | 8.668M |
| Current Ratio | 2.233 |